Medical Design Technology

News

Subscribe to MDT Magazine News

Digital Health and Fitness Technology Expands by Nearly 25 percent at 2013 International CES

October 29, 2012 1:00 pm | by The Associated Press | Comments

STOCKHOLM--(BUSINESS WIRE)--Oct 29, 2012--The Consumer Electronics Association (CEA) ® today announced the nearly 25 percent growth of digital health and fitness technology at the 2013 International CES ®. More than 215 exhibitors will showcase the latest digital health and fitness technologies at...

Cleveland Clinic and IBM Work to Advance Watson's Use in the Medical Training Field

October 29, 2012 12:29 pm | by Bio-Medicine.Org | Comments

CLEVELAND, Oct. 30, 2012 /- Cleveland Clinic and IBM (NYSE: IBM ) announced today the formation of a collaboration to advance Watson's use in the medical training field. The IBM team of researchers that created Watson will work with Cleveland Clinic clinicians, faculty and medical students to enhance the capabilities of Watson's Deep Question Answering technology for the...

Bandages Plus, Inc. Doral, Florida has been acquired by The Morrissey Group, LLC

October 29, 2012 11:13 am | by Bio-Medicine.Org | Comments

FORT LAUDERDALE, Fla., Oct. 29, 2012 /- Announced today, Bandages Plus, Inc. Doral, Florida has been acquired by The Morrissey Group, LLC.  Bandages Plus is an international distributor of Compression Therapy products useful in the treatment of chronic edema.  Products are marketed directly to hospitals, physicians, physical therapists and other medical service providers a...

Advertisement

XBiotech Reports Positive Phase II Interim Analysis Results From Type 2 Diabetes Study

October 29, 2012 11:13 am | by Bio-Medicine.Org | Comments

AUSTIN, Texas, Oct. 29, 2012 /- XBiotech, a privately held biotechnology company, announced positive interim analysis results today from a Phase II study using a True Human monoclonal antibody (MABp1) in patients with type 2 diabetes.  Results from this study continue to reinforce the role of IL-1α as a master regulator of chronic inflammation in multiple disease st...

Global Proteomics Market Worth $17.2 Billion by 2017

October 29, 2012 10:46 am | by Bio-Medicine.Org | Comments

DALLAS, October 29, 2012 /- The "Proteomics Market (Protein Microarray, Mass Spectrometry, NMR Spectroscopy, Chromatography, Electrophoresis, Surface Plasmon Resonance, Protein Fractionation, X-ray Crystallography, Immunoassay) - Instruments, Reagents and Services - Trends and Global Forecasts to 2017" analyzes and studies the major market drivers, restraints, and opportunities in...

Researchers Identify Biomarkers of Aggressive Behavior and Therapeutic Targets for Adult B-acute Lymphoblastic Leukemia

October 29, 2012 10:00 am | by AACR | Comments

B-acute lymphoblastic leukemia is often an aggressive disease in adults. Changes in DNA modification and packaging dictate aggressiveness. Researchers identified possible indicators of those most at risk and potential therapeutic targets. PHILADELPHIA — New insight into the aggressive behavior of certain adult B-acute lymphoblastic leukemias has provided researchers with a potential new prognostic biomarker and [...]

EnteroMedics narrows losses in Q3, aims for 2014 commercialization

October 29, 2012 9:45 am | by Mass Device | Comments

EnteroMedics narrows Q3 losses by 20%, with lower spending on research & development in the 3 months ended September 30. EnteroMedics (NSDQ:ETRM) narrowed its losses during its 3rd quarter, cutting its research & development expenses nearly in half. News Well, 2012, MassDevice Earnings Roundup, Q3, Wall Street Beat, Weight lossread more

Alliance HealthCare Services Expects to Reach Agreement to Amend Its Credit Agreement Today

October 29, 2012 9:00 am | by The Associated Press | Comments

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Oct 29, 2012--Alliance HealthCare Services, Inc. (NYSE:AIQ) (the “Company” or “Alliance”), a leading national provider of outpatient diagnostic imaging and radiation therapy services, announced that it expects to reach an agreement with lenders for a 2 nd...

Advertisement

Dentsply's a mixed bag in Q3

October 29, 2012 8:45 am | by Mass Device | Comments

Dentsply's Q3 earnings slide nearly 12% on revenues that grew more than 12%. Dentsply International (NSDQ:XRAY) reported a 12.3% increase in sales during the 3 months ended Sept. 30, 2012, but saw a 11.9% decline in net income. News Well, 2012, Dental , MassDevice Earnings Roundup, Q3, Wall Street Beatread more

5 steps to medical device cybersecurity, from Microsoft's U.K. security chief

October 29, 2012 8:35 am | by Mass Device | Comments

Protecting medical devices from malware and viruses means practicing good cybersecurity "hygiene," Microsoft's U.K. chief security advisor says. Cybersecurity is a fairly new idea for many medical device makers, but the industry can learn from technologies that came before in developing means of protecting devices from malware, viruses and other threats. Microsoft's U.K. chief security advisory Stuart Aston took to the company's blog to address the growing concern, offering steps to consider when developing a security strategy for medical devices, including realigning priorities to bump cybersecurity in the top tier and shelling out for updated software when possible. News Well, Hacking, Health Information Technology, Medical device hackingread more

NuVasive Announces Outstanding Showing at NASS 2012

October 29, 2012 8:30 am | by The Associated Press | Comments

NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, featured its procedural solutions and sophistication from years of experience in lateral approach spine surgery at the North...

J&J surgical stapler recall gets Class I status from the FDA | MassDevice.com On Call

October 29, 2012 8:29 am | by Mass Device | Comments

Johnson & Johnson subsidiary Ethicon Endo-Surgery's global surgical stapler recall gets Class I status from the FDA over concerns that difficulties with the devices' firing mechanisms may injure patients. MASSDEVICE ON CALL — Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon Endo-Surgery's global surgical stapler recall got Class I status from the FDA over concerns that issues with the devices' firing mechanisms may injure patients. News Well, Food & Drug Administration (FDA), On Call, Recalls, Surgicalread more

Amdocs Launches Cloud-Based eHealth Solutions to Give Service Providers Fast Entry to Growing Market

October 29, 2012 7:00 am | by Bio-Medicine.Org | Comments

CHICAGO, Oct. 29, 2012 /- Amdocs (NYSE: DOX ), the leading provider of customer experience systems and services, launched two new cloud-based solutions to provide support for in-home management and monitoring of elderly and chronically-ill patients today at 4G World. Amdocs Home Health Monitoring and Amdocs' solution for Aging in Place enable service providers to enter the ra...

Teleflex Introduces ISO-Gard Circuit Technology to Improve Support of Clinical Practice Guidelines

October 29, 2012 7:00 am | by The Associated Press | Comments

LIMERICK, Pa.--(BUSINESS WIRE)--Oct 29, 2012--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, is introducing new ISO-Gard ® Circuit Technology as a featured addition to their line of Hudson RCI ® respiratory products, which includes...

Global ECG Monitoring Systems Market is Expected to Reach USD 822.1 Million in 2016: Transparency Market Research

October 29, 2012 5:57 am | by Bio-Medicine.Org | Comments

ALBANY, New York, October 29, 2012 /- According to a new market report published by Transparency Market Research ( http://www.transparencymarketresearch.com ) " ECG Monitoring Systems Market - Global Industry Analysis by Type, Size, Share and Forecast, 2011 - 2016 ," the global ECG monitoring systems market is estimated to reach a market size worth USD 822.1 million in 2016, growi...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading